Apixaban

  • Référence produit : C2109
  • Numéro de CAS : 503612-47-3
  • Formule moléculaire : C25H25N5O4
  • Masse molaire : 459,50 g.mol-1
  • Pureté min. : 98,00 %
  • Synonymes : Apixabin
  • Solubilité : se référer au COA

  • Stabilité : ≥ 1 an
  • Expédition : 24/48h pour les produits en stock
Faire une demande
Référence du produit : C2109
Masse
Qté

Description

Apixaban is intended for Pharmaceuticals applications. Apixaban is a potent, direct, selective, and orally active inhibitor of coagulation factor Xa. All information about Apixaban is provided in the MSDS. We deliver compounds with high purity levels and a comprehensive Certificate of Analysis. Connect to your member account to consult the documents.

Références

  1. Rivaroxaban and apixaban in orthopaedics: is there a difference in their plasma concentrations and anticoagulant effects? Blood Coagul Fibrinolysis. 2015 Dec; 26(8): 925–933. [...]
  2. A UHPLC-MS/MS method to simultaneously quantify apixaban, edoxaban and rivaroxaban in human plasma and breast milk: For emerging lactation studies Journal of Chromatography B Volume 1144, 1 May 2020, 122095 [...]
  3. In vitro assessment of P-gp and BCRP transporter-mediated drug–drug interactions of riociguat with direct oral anticoagulants fundamental & clinical pharmacology, volume 34, issue 1, February 2020, p. 109-119 [...]
  4. Resolving DOAC interference on antithrombin activity testing on a FXa based method by the use of activated carbon. Clinica Chimica Acta - Volume 538, 1 January 2023, Pages 216-220 [...]

Recommandation